JD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease |  | 2020 | 404 | 2 | ||
| A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa | Science Translational Medicine | | 2017 | 634 | 2 | ||
| Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey | PLOS ONE |  | 2017 | 505 | 224 | ||
| Clinical Management of Ebola Virus Disease in the United States and Europe | New England Journal of Medicine | | 2016 | 1,226 | 355 | ||
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | | 2016 | 933 | 277 | ||
| Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone | Clinical infectious diseases | | 2016 | 640 | 466 | ||
| The 2014–2015 Ebola outbreak in West Africa: Hands On | Antimicrobial Resistance and Infection Control | | 2016 | 542 | 237 | ||
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases | | 2015 | 705 | 0 | ||
| Ebola: le point au crépuscule d'une épidémie inattendue | Revue médicale suisse | | 2015 | 140 | 150 | ||
| Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report | Lancet. Infectious diseases | | 2015 | 711 | 1 |
